eli lilly empower pharmacy

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

Houston Public Media · 22h

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

Quartz on MSN · 4h

Eli Lilly is stepping up its fight against copycat weight loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.

Pharmaceutical Technology4h

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

Modern Healthcare12d

Inside Eli Lilly’s digital health strategy for GLP-1s

Eli Lilly is partnering ... “Now, [Lilly and others] are like, ‘That's a great idea. We can do that too.’” LillyDirect also operates a self-pay pharmacy arm through dispensing provider ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Trending now